GVH Investigates iHerb Over Dietary Supplement Claims
Summary
The Hungarian Competition Authority (GVH) has initiated competition supervision proceedings against iHerb Netherlands BV and its U.S. parent company iHerb LLC on suspicion of using unlawful health-related claims and therapeutic effect claims in advertising food products and dietary supplements since November 2024. The investigation focuses on violations including health claims that violate sectoral regulations, claims attributing disease prevention or treatment properties, and products sold as dietary supplements without required registration with the National Centre for Public Health and Pharmacy. The case registration number is VJ/12/2026, and the standard procedural timeframe is three months, extendable twice by up to two months each.
“The GVH alleges that, among other things, the companies unlawfully use health-related claims and claims regarding therapeutic effect in the advertising of their food products and dietary supplements, as well as giving the impression that the products they sell can be lawfully marketed, thereby misleading consumers.”
Dietary supplement manufacturers and retailers selling into Hungary should audit their advertising claims for compliance with sectoral regulations governing health claims and therapeutic effect assertions. The investigation signals GVH's focus on enforcement in this area, and companies using similar marketing language should review whether their claims meet the standards GVH outlined in its April 2026 guidance document on food advertising.
About this source
GovPing monitors GVH Hungary News for new consumer protection regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 3 changes logged to date.
What changed
GVH has initiated a competition supervision proceeding against iHerb Netherlands BV and iHerb LLC for alleged violations in the advertising of food products and dietary supplements. The specific violations under investigation include using prohibited health claims such as 'contributes to maintaining heart and brain health' and 'helps neutralize free radicals,' claims attributing disease prevention or treatment properties such as 'Herbal pain reliever,' and giving the impression that unregistered dietary supplements are lawfully marketed.
Dietary supplement manufacturers and retailers should review their advertising claims for compliance with sectoral regulations on health, nutritional composition, and therapeutic effect claims. The investigation signals GVH's emphasis on examining market signals related to health claims in food and dietary supplement advertising. Companies marketing similar products in Hungary should ensure proper product registration and verify that all commercial communications meet due professional diligence requirements, particularly regarding legal framework compliance and translation accuracy.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Press room
- Main Page
- Press room
- Press releases
- Press releases 2025
- The Hungarian Competition Authority (GVH) is investigating companies involved in the distribution and sale of dietary supplements
2026. Apr. 22.
The investigation was launched due to health and remedial claims, as well as unlawful distribution
Budapest, April 21, 2026 – The Hungarian Competition Authority (GVH) has initiated a competition supervision proceeding against iHerb Netherlands BV, based in the Netherlands, and its U.S. parent company, iHerb LLC. The GVH alleges that, among other things, the companies unlawfully use health-related claims and claims regarding therapeutic effect in the advertising of their food products and dietary supplements, as well as giving the impression that the products they sell can be lawfully marketed, thereby misleading consumers. The competition authority issued a guidance document in early April to clarify the claims that may be used in the advertisement of food products.
The Hungarian Competition Authority has initiated an investigation against iHerb Netherlands BV and its U.S. parent company, iHerb LLC, on suspicion that the companies have violated provisions concerning the promotion of food and dietary supplements in several respects. The companies are suspected of
- using health claims that violate sectoral regulations (“contributes to maintaining heart and brain health,” “helps neutralize free radicals”);
- using claims that attribute properties to their products related to the prevention, treatment, or curing of human diseases (“Herbal pain reliever,” “Targets pain where it starts, delivering effective ginger to relieve mild pain.”);
- giving the impression that certain products are being sold legally, even though the products in question are classified as dietary supplements and, contrary to regulations, have not been registered with the National Centre for Public Health and Pharmacy; during the promotion of certain dietary supplements and food products, starting in November 2024.
The GVH also noted that the companies’ commercial communications likely do not, in general, meet the requirement of due professional diligence, as the design, creation, publication, and monitoring of the communications are based, among other things, on the incorrect legal framework and on unverified machine translations. The companies subject to the proceedings thus likely fail to adequately ensure the prevention of the above-mentioned potential violations, and in doing so may mislead consumers.
The initiation of these proceedings does not imply that the companies have committed the suspected infringements. The procedures aim to establish the facts and, where appropriate, confirm the alleged unlawful conduct. The statutory timeframe for each proceeding is three months, which may be extended twice, each time by up to two months, if justified. As required by the Competition Act, the period between the GVH’s request for information and its fulfilment by the parties does not count towards the procedural time limit.
The Hungarian Competition Authority places great emphasis on examining market signals related to the use of health claims and claims regarding therapeutic effects in the advertisement of food products – and, within that category, dietary supplements in particular – as well as on conducting competition supervision proceedings in this area. Based on the GVH’s extensive procedural experience, companies frequently use such claims, but often make mistakes and commit violations when formulating them. In April 2026, the Hungarian Competition Authority published a guidance document aimed at helping companies that strive to comply with the law to understand the regulatory framework concerning health, nutritional composition, and remedial claims.
The guidance document is available on the website of the GVH in Hungarian.
The official registration number of the case is VJ/12/2026.
GVH Press
Further information:
Horváth Bálint, Head of Communications +36 20 238 6939
Parties
Related changes
Get daily alerts for GVH Hungary News
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from GVH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when GVH Hungary News publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.